Cotización Magenta Therapeutics - MGTA | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Magenta Therapeutics Inc (MGTA) Cotización

Magenta Therapeutics Inc (MGTA)

11.1936

0.00

( 0.00% )

Actualizado: 18:00:00

Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Último Precio

11.1936

Postura de Compra

0.6802

Postura de Venta

0.74

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

11.1936

Precio de Apertura

-

Hora

Última hora de negociación

-

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MGTA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Magenta Therapeutics?

El precio actual de las acciones de Magenta Therapeutics es US$ 11.1936

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Magenta Therapeutics?

Magenta Therapeutics ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
SLXNSilexion Therapeutics Corporation	US$ 1.22 (110.34%)	167M
YIBOPlanet Image International Ltd	US$ 5.095 (65.42%)	46.95M
RNAZTransCode Therapeutics Inc	US$ 10.87 (59.15%)	14.04M
BACKIMAC Holdings Inc	US$ 1.1708 (41.23%)	51.99M
TRIBTrinity Biotech PLC	US$ 1.06 (39.47%)	97.64M
LPTXLeap Therapeutics Inc	US$ 0.6652 (-70.44%)	7.28M
STSSSharps Technology Inc	US$ 0.45555 (-68.80%)	10.92M
SABSSAB Biotherapeutics Inc	US$ 2.156 (-50.55%)	872.97k
MGOLMGO Global Inc	US$ 0.1791 (-36.71%)	13.51M
INKTMiNK Therapeutics Inc	US$ 6.60 (-25.33%)	28.8k
HEPAHepion Pharmaceuticals Inc	US$ 0.2138 (29.58%)	224.97M
NVDANVIDIA Corporation	US$ 120.6001 (1.84%)	217.94M
SLXNSilexion Therapeutics Corporation	US$ 1.2103 (108.67%)	167.08M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.503 (22.06%)	101.07M
TRIBTrinity Biotech PLC	US$ 1.0699 (40.78%)	97.64M

INFINITI

INFINITI 2 años hace

Let’s goooo$$$

Jayzp

Jayzp 2 años hace

ther stock good news

https://theralink.com/theralink-technologies-achieves-ny-state-department-of-health-clinical-laboratory-permit-for-its-golden-colorado-laboratory/

harry crumb

harry crumb 2 años hace

INFINITI

INFINITI 2 años hace

Stocks to Watch: Apple, Amazon.com, Alphabet, Magenta Therapeutics, Clorox

Source: Dow Jones News
Sabela Ojea

Apple Inc. posted its first quarterly revenue decline in nearly four years as manufacturing disruptions in China curbed its ability to deliver premium iPhones. Shares of the iPhone maker fell 2.4% in after-hours trading on Thursday.

Amazon.com Inc. warned of a period of reduced growth and signaled the difficult economic environment is denting the performance of its cloud-computing business that's been a profit engine for the company, despite also beating Wall Street expectations for fourth-quarter sales. Shares of the ecommerce giant dived 4.7% in after-hours trading.

Alphabet Inc. reported its first drop in advertising revenue since the beginning of the pandemic in the fourth quarter. Shares of Google's parent dropped 3.4% in after-hours trading.

Magenta Therapeutics Inc. said it could be up for sale as part of review of strategic alternatives. Shares of the clinical-stage biotechnology company surged 47% in after-hours trading.

Clorox Co. reported better-than-expected profit in its fiscal second quarter as the consumer products company cut costs and adjusted prices to offset inflation. Shares increased 3.6% in after-hours trading.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

February 02, 2023 19:06 ET (00:06 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

INFINITI

INFINITI 2 años hace

Looking good here load up $$$$$

ROCKY LEDGE

ROCKY LEDGE 5 años hace

ROCKY LEDGE

ROCKY LEDGE 5 años hace

7.61....bottom in. Bounce. Imho.

MGTA

robertcshea

robertcshea 6 años hace

PJ- are you still following MGTA? Looks like your heavy over $19 call was spot on. Interested if you have a take on the name and if you are involved or have an opinion on it back down in the $13s.

pj McMulligan

pj McMulligan 6 años hace

MGTA appears top-heavy here over $19 imo... anyone know what's driving this one up after the Goldman-Sachs downgrade?

https://www.stockcharts.com/h-sc/ui?s=MGTA&p=D&b=5&g=0&id=p86953380658

Magenta Therapeutics

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones